Browsing by Contributors Held, Claes

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
آ ب پ ت ث ج چ ح خ د ذ ر ز ژ س ش ص ض ط ظ ع غ ف ق ک گ ل م ن و ه ی
 
Showing results 1 to 16 of 16
PreviewIssue DateTitleContributor(s)
2016 EHJ Volume 37 Issue 20 May (5).pdf.jpg2016The ABC ( age , biomarkers , clinical history ) stroke risk score : a biomarker-based risk score for predicting stroke in atrial fibrillationAlexander, John H; Hanna, Michael; Held, Claes; Hijazi, Ziad; Lindba, Johan; Hylek, Elaine M; Lopes, Renato D; Oldgren, Jonas; Siegbahn, Agneta; Stewart, Ralph A H; White, Harvey D; Granger, Christopher B; Wallentin, Lars; Investigators, Stability
2018 EHJ Volume 39 Issue 6 February (5).pdf.jpg2018Atrial fibrillation A biomarker-based risk score to predict death in patients with atrial fibrillation : the ABC ( age , biomarkers , clinical history ) death risk scoreHijazi, Ziad; Oldgren, Jonas; Lindba, Johan; Alexander, John H; Connolly, Stuart J; Eikelboom, John W; Ezekowitz, Michael D; Held, Claes; Hylek, Elaine M; Lopes, Renato D; Yusuf, Salim; Granger, Christopher B; Siegbahn, Agneta; Wallentin, Lars
2017 ATsurgery Volume 104 Issue 3 September (4).pdf.jpg2017Cardiac Involvement in Diabetes: The Dark Side of the Moon Maurizio Galderisi, Roberta Esposito, Bruno Trimarco 1717Stewart, Ralph A H; Held, Claes; Hadziosmanovic, Nermin; Armstrong, Paul W; Cannon, Christopher P; Granger, Christopher B; Hagström, Emil; Hochman, Judith S; Koenig, Wolfgang; Lonn, Eva; Nicolau, José C; Steg, Philippe Gabriel; Vedin, Ola; Sawaki, Daigo; Czibik, Gabor; Volpi, Chiara; Canoui-poitrine, Florence; Thibault, Hélène
1264.full.pdf.jpg21-May-2015Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trialHeld, Claes; Hylek, Elaine M; Alexander, John H; Hanna, Michael; Lopes, Renato D; Wojdyla, Daniel M; Thomas, Laine; Al-Khalidi, Hussein; Alings, Marco; Xavier, Dennis; Ansell, Jack; Goto, Shinya; Ruzyllo, Witold; Rosenqvist, Mårten; Verheugt, Freek W A; Zhu, Jun; Granger, Christopher B; Wallentin, Lars
2016 EHJ Volume 37 Issue 25 July (11).pdf.jpg2016Dietary patterns and the risk of major adverse cardiovascular events in a global study of high-risk patients with stable coronary heart diseaseStewart, Ralph A H; Wallentin, Lars; Benatar, Jocelyne; Danchin, Nicolas; Held, Claes; Husted, Steen; Lonn, Eva; Stebbins, Amanda; Chiswell, Karen; Vedin, Ola; Watson, David; White, Harvey D
2017 AHJ Volume 187 May (20).pdf.jpg2017Differential occurrence, profile, and impact of first recurrent cardiovascular events after an acute coronary syndromeHess, Connie N.; Clare, Robert M.; Neely, Megan L.; Tricoci, Pierluigi; Mahaffey, Kenneth W.; James, Stefan K.; Alexander, John H.; Held, Claes; Lopes, Renato D.; Fox, Keith a.a.; White, Harvey D.; Wallentin, Lars; Armstrong, Paul W.; Harrington, Robert a.; Ohman, Erik
2017 AHJ Volume 187 May (22).pdf.jpg2017An examination of the relationship between serum uric acid level, a clinical history of gout, and cardiovascular outcomes among patients with acute coronary syndromePagidipati, Neha J.; Hess, Connie N.; Clare, Robert M.; Akerblom, Axel; Tricoci, Pierluigi; Wojdyla, Daniel; Keenan, Robert T.; James, Stefan; Held, Claes; Mahaffey, Kenneth W.; Klein, Alyssa B.; Wallentin, Lars; Roe, Matthew T.
1325.pdf.jpg15-May-2015Glycoprotein IIb/IIIa Receptor Inhibitors in Combination With Vorapaxar, a Platelet Thrombin Receptor Antagonist, Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes (from the TRACER Trial)Cornel, Jan H; Tricoci, Pierluigi; Lokhnygina, Yuliya; Moliterno, David J; Wallentin, Lars; Armstrong, Paul W; Aylward, Philip E; Clare, Robert M; Chen, Edmond; Leonardi, Sergio; Van de Werf, Frans; White, Harvey D; Held, Claes; Strony, John; Mahaffey, Kenneth W; Harrington, Robert A
2017 EHJ Volume 38 Issue 41 November (9).pdf.jpg2017Improved outcomes in patients with ST -elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments : experiences from the SWEDEHEARTregistry 1995 – 2014Szummer, Karolina; Wallentin, Lars; Lindhagen, Lars; Alfredsson, Joakim; Erlinge, David; Held, Claes; James, Stefan; Kellerth, Thomas; Lindahl, Bertil; Ravn-fischer, Annica; Rydberg, Erik; Yndigegn, Troels; Jernberg, Tomas
2017 BJH Volume 129 Issue 22 June (6).pdf.jpg2017Intracranial hemorrhage in patients with atrial fi brillation receiving anticoagulation therapyKolls, Bradley J; Wojdyla, Daniel M; Bushnell, Cheryl D; Lopes, Renato D; Guimara, O; Hanna, Michael; Easton, J Donald; Thomas, Laine; Wallentin, Lars; Al-khatib, Sana M; Held, Claes; Gabriel, Pedro; Barros, Melo De; Alexander, John H; Granger, Christopher B; Diener, Ha
2016 Lancet Volume 387 Issue 10035 June (4).pdf.jpg2016The novel biomarker-based ABC ( age , biomarkers , clinical history ) -bleeding risk score for patients with atrial fi brillation : a derivation and validation studyHijazi, Ziad; Oldgren, Jonas; Lindbäck, Johan; Alexander, John H; Connolly, Stuart J; Eikelboom, John W; Ezekowitz, Michael D; Held, Claes; Hylek, Elaine M
2018 EHJ Volume 39 Issue 42 November (8).pdf.jpg2018Relations between implementation of new treatments and improved outcomes in patients with non-ST -elevation myocardial infarction during the last 20 years : experiences from SWEDEHEARTregistry 1995 to 2014Szummer, Karolina; Wallentin, Lars; Lindhagen, Lars; Alfredsson, Joakim; Erlinge, David; Held, Claes; James, Stefan; Kellerth, Thomas; Lindahl, Bertil; Ravn-fischer, Annica; Rydberg, Erik; Yndigegn, Troels; Jernberg, Tomas
2017 JACC Volume 70 Issue 7 August (2).pdf.jpg2017Subcutaneous Implantable Cardioverter-De fi brillator Finding a Place in Sudden Cardiac Death Prevention: Emerging or Emerged? Jeanne E. Poole, Jordan M. Prutkin 842Lindholm, Daniel; Lindbäck, Johan; Armstrong, Paul W; Budaj, Andrzej; Cannon, Christopher P; Granger, Christopher B; Hagström, Emil; Held, Claes; Koenig, Wolfgang; Östlund, Ollie; Stewart, Ralph A H; Soffer, Joseph; White, Harvey D; Winter, Robbert J De; Steg, Philippe
2017 EHJ Volume 38 Issue 11 March (11).pdf.jpg2017Trade-off of myocardial infarction vs . bleeding types on mortality after acute coronary syndrome : lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome ( TRACER ) randomized trialValgimigli, Marco; Costa, Francesco; Lokhnygina, Yuliya; Clare, Robert M; Wallentin, Lars; Moliterno, David J; Armstrong, Paul W; White, Harvey D; Held, Claes; Aylward, Philip E; Werf, Frans Van De; Harrington, Robert A; Mahaffey, Kenneth W; Tricoci, Pierluigi
EHJ 2017 Volume 38 Issue 11 March (11).pdf.jpg2017Trade-off of myocardial infarction vs . bleeding types on mortality after acute coronary syndrome : lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome ( TRACER ) randomized trialValgimigli, Marco; Costa, Francesco; Lokhnygina, Yuliya; Clare, Robert M; Wallentin, Lars; Moliterno, David J; Armstrong, Paul W; White, Harvey D; Held, Claes; Aylward, Philip E; Werf, Frans Van De; Harrington, Robert A; Mahaffey, Kenneth W; Tricoci, Pierluigi
2017 EHJ Volume 38 Issue 37 October (9).pdf.jpg2017Visit-to-visit variability of blood pressure and cardiovascular outcomes in patients with stable coronary heart disease . Insights from the STABILITY trialVidal-petiot, Emmanuelle; Stebbins, Amanda; Chiswell, Karen; Ardissino, Diego; Aylward, Philip E; Cannon, Christopher P; Corrales, Marco A Ramos; Held, Claes; Stewart, Ralph A H; Wallentin, Lars; Luis, L; White, Harvey D; Steg, Philippe Gabriel